Liminal BioSciences Provides Update on Progress on BLA for Ryplazim®(plasminogen)

– FDA assigns PDUFA target action date of March 5, 2021LAVAL, QC and CAMBRIDGE, England, Sept. 21, 2020 /CNW Telbec/ – Liminal BioSciences Inc. …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.